slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 7,831-7,860
Pages 395
Rows per page 30
Slide function
7,831-7,860 of 11,828
17
The trial met Simon 2-stage criteria but was discontinued to prioritize a study with Tagrisso.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
19
The slide includes a timeline of the study and two line charts showing tumor volume over time for different treatment groups.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The slide outlines a multi-phase clinical trial structure (Phase 1, 2a, 2b) and provides specific patient counts and interim analysis milestones.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
21
Includes a table of enrollment/DLTs and a swimmer plot for PFS.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
24
Includes Kaplan-Meier curves for Overall Survival (A) and Progression-free Survival (B).Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
25
Kaplan-Meier survival curve showing PFS. Mentions Tecentriq as brand name for Atezolizumab.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
26
Includes bioluminescence imaging and quantitative bar chart with statistical significance markers (p-values).Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
27
The slide shows four separate bar charts comparing Control, Atezo (Tecentriq), REQORSA, and Combination therapies across four immune cell types.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
29
The chart shows statistical significance (p-values) comparing treatment groups against controls.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
38
The slide compares AAV8-PM (therapeutic) against AAV8-GFP (control) and an untreated control group.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
39
The slide uses a comparative analogy between mouse lifespan and human lifespan to suggest long-term efficacy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
41
NHP = Non-Human Primate. STZ likely refers to Streptozotocin, a compound used to induce diabetes in animal models.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
42
ATTD likely refers to the Advanced Technologies & Treatments for Diabetes conference.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
56
Includes bioluminescence imaging of tumor xenografts and bar charts quantifying Active T cells, MDSC, Active NK cells, and DC populations.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
57
The slide highlights a triple combination therapy (Reqorsa + Carbo + Pembro) compared to standard of care.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
07
Includes a Venn diagram illustrating the intersection of 'Digitally Enabled' and 'Beyond Plastic Brand Leadership'.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
The chart uses a trend line to highlight the improvement over five years.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
The chart illustrates cohort decay and stabilization over time.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The slide uses two bar charts to demonstrate customer cohort value expansion over time.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
The slide uses a testimonial to reinforce the strategic shift into new categories.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The chart uses a dual-axis approach (implied) to show growth trends for two different metrics over time, with a 'Runway For Growth' arrow highlighting the upward trajectory.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The chart uses a legend for categories and arrows to indicate growth percentages between periods.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
VMS likely stands for Vitamins, Minerals, and Supplements.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
Includes footnotes for data sources.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
The chart highlights a 'pandemic bump' in 2020-2021 and projects a return to positive EBITDA in 2024.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
29
The chart uses a visual arrow to emphasize the projected growth trend from Q3 to Q4.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
30
Grove | Investor Presentation Deck | 35 slidesGrove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
10
The slide uses a grid of callout boxes to highlight market leadership, growth, and third-party validation.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses a three-column layout to categorize performance metrics.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Traction1 hit
16
The chart illustrates a clear trend of improving financial performance over the course of 2023.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Traction1 hit